Institutional Property Advisors Expands in Northern California

PALO ALTO, Calif.--(BUSINESS WIRE)--May 7, 2025--

Institutional Property Advisors (IPA), a specialized division of Marcus & Millichap (NYSE:MMI) dedicated to serving the company’s institutional clients, announced today that Rob LeDoux has joined IPA as a senior director in Palo Alto, California. LeDoux will broker multifamily investment property transactions on behalf of institutional and major private clients in partnership with the IPA Northern California team of Philip Saglimbeni, Salvatore Saglimbeni, Stan Jones, and Alex Tartaglia.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507179765/en/

“IPA has built and maintained a decades-long dominant market share position throughout the Bay Area and greater Northern California,” said Andrew Leahy, national director of IPA’s multifamily division. “Hiring Rob deepens our ability to serve investors pursuing multifamily investment opportunities throughout Northern California and furthers our continued growth and expansion of the IPA platform.”

Previously a director at Walker & Dunlop, LeDoux joins IPA with 15 years of commercial real estate industry experience serving institutional investors throughout Northern California. Over the course of his career, he has been involved in transacting over 15,000 units totaling more than $4 billion in sales volume.

With the addition of LeDoux, the IPA team in Northern California has over a century of combined multifamily commercial real estate investment experience. In the last decade alone, the team has closed over 221 transactions on behalf of their clients valued at over $15 billion.

“One of the great benefits IPA provides to institutional and major private clients in Northern California is the ability to deliver advisory, acquisition and disposition services with a focused team of investment professionals,” said Philip Saglimbeni. “Rob’s work ethic, transactional expertise, and versatile skill set make him a valuable addition. We are very pleased to welcome him on behalf of our clients.”

About Institutional Property Advisors (IPA)

Institutional Property Advisors (IPA) is a division of Marcus & Millichap (NYSE: MMI), a leading commercial real estate services firm in North America. IPA’s combination of real estate investment and capital markets expertise, industry-leading technology, and acclaimed research offer customized solutions for the acquisition, disposition and financing of institutional properties and portfolios. For more information, please visitwww.institutionalpropertyadvisors.com

About Marcus & Millichap, Inc. (NYSE: MMI)

Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. Marcus & Millichap closed 7,836 transactions with a sales volume of approximately $49.6 billion in 2024. The company had 1,712 investment sales and financing professionals in more than 80 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate at year end. For additional information, please visitwww.MarcusMillichap.com.

Rob LeDoux

WOODBRIDGE, Conn.--(BUSINESS WIRE)--Jan 12, 2026--

ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market. To support its growth in the region, ChemWerth has hired Chandrakanth Reddy as general sales manager of its India office.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260111302280/en/

“The addition of a general sales manager in India signals our desire to grow our presence and customer base in the world’s most important generic pharmaceutical market,” said Pete Werth III, president, ChemWerth. “Chandrakanth will add tremendous value for our customers and contract manufacturing organizations (CMOs) in India.”

Reddy is a seasoned pharmaceutical professional with more than 16 years of experience spanning API sourcing, business development, market expansion and regulatory-driven commercial strategy. He has successfully led high-value markets across India, the Middle East, North Africa, Europe, and the United States, building strong customer partnerships and supporting sustainable revenue growth.

In his new role, Reddy will be responsible for leading ChemWerth’s sales strategy in India and strengthening regional customer relationships. He will also support the company’s focused initiative to roll out new generic APIs in the market, including fermentation, peptide and oncology injectable APIs.

“After reviewing ChemWerth’s strategic plan to unveil a strong pipeline of new generic fermentation, peptide and oncology injectable APIs for the Indian market, I knew that was something I wanted to be a part of,” said Reddy.

About ChemWerth, Inc.:

Established in 1982, ChemWerth is a full-service generic active pharmaceutical ingredient (API) development and supply company providing cGMP-quality APIs to regulated markets worldwide. ChemWerth is a global company headquartered in the United States, with offices in China and India. For more information, please visit www.chemwerth.com.

Chandrakanth Reddy has joined ChemWerth, Inc., as general sales manager of its India office.